Skip to content
Abierto

Special notice

NMRC Bone Marrow Program

N3239824Q9982

Department of the Navy, Naval Medical Research Center. Medical Laboratories.

Awarded

Caredx Lab Solutions Inc.

$250,000.00 obligated so far on USAspending

Description

As published on SAM.gov.

The United States Department Of Naval Medical Research Command (NMRC) intends to award a sole source contract, CareDX Lab Solutions., West Chester, PA. 19382. This notice is not a request for competitive proposals however If interested Government shall consider all responses. The DoD Bone Marrow Program mission in the treatment of radiation and chemical weapon exposure is unique to the Armed Forces.

When prescribed 90% of drugs work only in 30-50% this is because 90% of individuals are likely to have different clinically actionable pharmacogenetic genotype. There is a strong and well documented correlation between drug efficacy and variation in genes responsible for drug metabolism or transport (Pharmacogenetics; PGx). Maintaining an optimal level of immunosuppression is critical for successful post-transplant management after HSCT.

Too low level of immunosuppression might lead to GvHD and relapse, whereas too high level of immunosuppression might lead to toxicity and deleterious side effects. Metabolism and efficacy of most commonly used immunosuppressive drugs are modulated by pharmacogenes. Variations in pharmacogenes are widespread across different populations, with many of them frequent in minority groups. Genetic testing allows for identification of patients carrying deleterious variants in pharmacogenes.

The proposed action is the continuation of research to develop an NGS-based assay using hybrid capture technology to assess response to various immunosuppression protocols (drugs) in the surveillance of HSCT patients.

1. Stage 1 Optimization Personnel Hours 2. Stage 1 Optimization Reagents Cost 3. Stage 2 Verification Personnel Hours 4. Stage 2 Verification Reagents Cost 5. Stage 3 Software Development - Initiation phase Personnel hours Period Of Performance Sep 2024 - May 2025. The NAICS code for this action is 621511. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items.

NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a Unique Entity Identification Number (UEI).

A Sam.gov number may be acquired free of charge by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220. See attached J&A for specifics. Email your Quote to the following:

shamai.m.carter.civ@health.mil deborah.m.sharpe2.civ@health.mil

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
KHHBJ9FJR225
CAGE
6E5A4
Vendor location
West Chester, PA
Contract
N3239824P0032, purchase order
Obligated
$250,000.00
Actions
1 between June 12, 2024 and June 12, 2024
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Stage 1 Optimization Reagents Cost
Match
solicitation number N3239824Q9982 equals the FPDS solicitation identifier; same awarding office N32398 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 7, 2024

    Special notice

    Due May 22, 2024 at 12:00 PM EDT. SAM.gov, notice 4d39d4910f9342ab884a17da65073c2a

Points of contact